29 related articles for article (PubMed ID: 16704680)
1. Serum IGFBP-1 as a promising diagnostic and prognostic biomarker for colorectal cancer.
Huang BL; Wei LF; Lin YW; Huang LS; Qu QQ; Li XH; Chu LY; Xu YW; Wang WD; Peng YH; Wu FC
Sci Rep; 2024 Jan; 14(1):1839. PubMed ID: 38246959
[TBL] [Abstract][Full Text] [Related]
2. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
Luo Y; Hong CQ; Huang BL; Ding TY; Chu LY; Zhang B; Qu QQ; Li XH; Liu CT; Peng YH; Guo HP; Xu YW
Ann Med; 2022 Dec; 54(1):2153-2166. PubMed ID: 35930383
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and Prognostic Value of Circulating MicroRNAs for Esophageal Squamous Cell Carcinoma: a Systematic Review and Meta-analysis.
Yao C; Liu HN; Wu H; Chen YJ; Li Y; Fang Y; Shen XZ; Liu TT
J Cancer; 2018; 9(16):2876-2884. PubMed ID: 30123356
[No Abstract] [Full Text] [Related]
4. The low IGFBP-3 level is associated with esophageal cancer patients: a meta-analysis.
Song G; Liu K; Zhu X; Yang X; Shen Y; Wang W; Shi G; Li Q; Duan Y; Zhao Y; Feng G
World J Surg Oncol; 2016 Dec; 14(1):307. PubMed ID: 27978831
[TBL] [Abstract][Full Text] [Related]
5. Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers.
Kashyap MK
Tumour Biol; 2015 Nov; 36(11):8247-57. PubMed ID: 26369544
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma.
Zhang T; Shen H; Dong W; Qu X; Liu Q; Du J
Sci Rep; 2014 Oct; 4():6855. PubMed ID: 25358597
[TBL] [Abstract][Full Text] [Related]
7. Combining proteomics, serum biomarkers and bioinformatics to discriminate between esophageal squamous cell carcinoma and pre-cancerous lesion.
Zhai XH; Yu JK; Lin C; Wang LD; Zheng S
J Zhejiang Univ Sci B; 2012 Dec; 13(12):964-71. PubMed ID: 23225851
[TBL] [Abstract][Full Text] [Related]
8. [Gastrointestinal cancer].
Takahashi Y
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1275-9. PubMed ID: 15332558
[TBL] [Abstract][Full Text] [Related]
9. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
Ławicki S; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of IGF-I and IGFBP-III and their relation with carcinoembryonic antigen and carbohydrate antigen 19-9 in cases of esophageal cancer.
Yilmaz O; Eroglu A; Dag E; Karaoglanoglu N; Yilmaz A
Int J Clin Pract; 2006 Dec; 60(12):1604-8. PubMed ID: 16704680
[TBL] [Abstract][Full Text] [Related]
11. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
[TBL] [Abstract][Full Text] [Related]
12. [Significance and expression of insulin-like growth factor 1 and IGF binding protein 3 in serum of patients with lung cancer].
Wang H; Wan YX; Zhang QK
Ai Zheng; 2004 Jun; 23(6):710-4. PubMed ID: 15191678
[TBL] [Abstract][Full Text] [Related]
13. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
[TBL] [Abstract][Full Text] [Related]
14. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
[TBL] [Abstract][Full Text] [Related]
15. The role of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in human esophageal cancer.
Sohda M; Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Fukai Y; Masuda N; Kuwano H
Anticancer Res; 2004; 24(5A):3029-34. PubMed ID: 15517912
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
